Laura Towart, Founder and CEO at Vivan Therapeutics, shared a post on LinkedIn:
“Reflecting on the incredible week I had at the World Health Expo Dubai 2026! The conference formerly known as Arab Health was one I consistently attended when I lived in the GCC (2011 -2016). Now it has really grown into its new name – friends and colleagues from all over the world congregated to engage in discussion, forge new collaborations, partnerships and trade ideas and products. Vivan Therapeutics is now a truly global company – a USA Icahn School of Medicine at Mount Sinai originated technology with offices in London, Abu Dhabi and Beijing.
I was honored to have the opportunity to represent Vivan Therapeutics and present our technology at the Healthcare UK pavilion. We are excited to announce initial IRB approval for a clinical registration study for our TuMatch software for personalized colorectal cancer treatment recommendations in the UAE at Burjeel Hospital with Khaled Musallam and Prof. Humaid Al -Shamsi and team.
I met our regulatory consulting partners Compliance MedQRA, Basant Bajpai for the first time in person. Im really impressed with the progress on our filings powered through their advanced AI driven eQMS platform, QraOne.”
Other articles featuring Laura Towart on OncoDaily.
